COMMUNIQUÉS West-GlobeNewswire

Extendicare Announces 2017 Third Quarter Results
09/11/2017
MARKHAM, Ontario, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today reported results for the three and nine months ended September 30, 2017. Results are presented in [...]
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017
09/11/2017
NORTHVALE, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP ), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products [...]
Argos Reports Third Quarter 2017 Financial Results and Operational Highlights
09/11/2017
DURHAM, N.C., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis [...]
Forward Pharma to Participate in the Nordic-American Life Science Conference
09/11/2017
COPENHAGEN, Denmark, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will participate in the Nordic- [...]
PLx Pharma Inc. Reports Third Quarter 2017 Results
09/11/2017
HOUSTON, Nov. 09, 2017 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP ) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 [...]
Aptevo Therapeutics Reports Third Quarter 2017 Financial Results
09/11/2017
Strengthened Cash Position to Support Ongoing R&D and Commercial Activities; Reported $107 Million in Cash at the End of the Third Quarter Expanded Novel Bispecific Antibody Portfolio Through Collaboration with [...]
Dyadic International Reports Third Quarter 2017 Financial Results
09/11/2017
JUPITER, Fla., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform [...]
Galena Biopharma Reports Third Quarter 2017 Financial Results
09/11/2017
SAN RAMON, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE ), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today reported [...]
Cytori Reports Third Quarter 2017 Business and Financial Results
09/11/2017
SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX ) (“Cytori” or the “Company”) today announced its third quarter 2017 financial results and provided updates on its corporate activity and [...]
Aileron Therapeutics Reports Third Quarter 2017 Financial Results
09/11/2017
Company continues to advance clinical trials of lead product candidate ALRN-6924 in PTCL and AML/MDS Two abstracts selected for oral presentations at American Society of Hematology Annual Meeting, highlighting potential [...]
Alphatec Holdings, Inc. Reports Third Quarter 2017 Financial Results
09/11/2017
Significant progress with transition to dedicated sales organization Continued improvement in operating expense and cash burn management CARLSBAD, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ [...]
Caladrius Biosciences Reports 2017 Third Quarter Results
09/11/2017
BASKING RIDGE, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update
09/11/2017
Announces Appointments of Michael Pehl as President and Chief Executive Officer and Brendan Delaney as Chief Commercial Officer Late-breaker Abstract on Updated Phase 2 Results of IMMU-132 in Patients with mTNBC [...]
Organovo Announces Fiscal Second-Quarter 2018 Results; Company Shifts Commercial Focus to Higher-Value Disease Modeling Opportunities and Updates Full-Year Fiscal 2018 Outlook
09/11/2017
SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today reported financial results for the fiscal second quarter of 2018 and updated its full-year fiscal 2018 outlook. The [...]
Immunomedics Appoints Michael Pehl President and Chief Executive Officer to Lead Next Phase of Transformative Growth
09/11/2017
MORRIS PLAINS, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that its Board of Directors has voted to appoint Michael Pehl as President [...]
Aclaris Therapeutics Mourns the Passing of Board Member Richard A. Bierly
09/11/2017
MALVERN, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq: ACRS ), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and [...]
KemPharm Reports Third Quarter 2017 Results and Provides Corporate Update
09/11/2017
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Development & Regulatory Highlights: Filed IND for KP484, A Super-Extended Release ADHD Methylphenidate Prodrug [...]
ChromaDex Reports Third Quarter 2017 Financial Results
09/11/2017
- Company Reports Third Quarter 2017 Revenue of $6.1 Million, Up 55% Compared to Last Year - - Continued Progress on Building a Consumer Products Platform Around TRU NIAGEN ™ - IRVINE, Calif., Nov. 09, 2017 (GLOBE [...]
Dova Pharmaceuticals Reports Third Quarter 2017 Operating and Financial Results
09/11/2017
NDA for avatrombopag submitted to FDA Conference call scheduled for 4:30 p.m. EST today DURHAM, N.C., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today reported its operating and [...]

Pages